STM publisher IOS Press, Netherlands, and the Editorial Board of the Journal of Alzheimer's Disease (JAD) have announced significant increase in the Journal's Impact Factor, from 4.081 to 5.101 for 2008, according to Thomson Reuters' Journal Citation Reports 2009.
The journal continues to strengthen and build on its lead as the most prolific and highly cited journal in the Alzheimer's disease (AD) field. With an Impact Factor of over 5, JAD is now at par with or exceeds the ranking of some of the most established and highly regarded journals in the neurosciences, pathology and biochemistry.
The Journal of Alzheimer's Disease (www.j-alz.com) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behaviour, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. Groundbreaking research that has appeared in the journal includes novel therapeutic targets, mechanisms of disease and clinical trial outcomes.
Search for more such STM products in K-Store
Discuss this NEWS
